ProPhase Labs, Inc.
PRPH
$0.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -35.82% | 908.80% | -11.64% | -67.59% | -80.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -35.82% | 908.80% | -11.64% | -67.59% | -80.65% |
| Cost of Revenue | -57.21% | 30.64% | -46.38% | -58.59% | -64.38% |
| Gross Profit | 1,022.67% | 126.40% | 181.44% | -91.24% | -100.96% |
| SG&A Expenses | -48.99% | 9.59% | 9.95% | 6.89% | 13.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.68% | 9.45% | -4.41% | -15.19% | -19.22% |
| Operating Income | 53.28% | 8.32% | 3.00% | -16.60% | -82.04% |
| Income Before Tax | 44.75% | 0.56% | -2.87% | -25.33% | -88.99% |
| Income Tax Expenses | -100.00% | 247.72% | 236.30% | 213.53% | 219.56% |
| Earnings from Continuing Operations | 52.78% | -103.95% | -94.83% | -116.79% | -202.35% |
| Earnings from Discontinued Operations | 325.16% | 357.39% | 535.78% | 848.45% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.37% | -50.25% | -57.55% | -82.79% | -217.98% |
| EBIT | 53.28% | 8.32% | 3.00% | -16.60% | -82.04% |
| EBITDA | 59.27% | 6.92% | 1.14% | -22.40% | -113.86% |
| EPS Basic | 92.12% | -4.83% | -20.36% | -47.32% | -152.28% |
| Normalized Basic EPS | 80.37% | 40.09% | 28.72% | 4.41% | -56.33% |
| EPS Diluted | 92.03% | -5.14% | -20.61% | -47.54% | -152.51% |
| Normalized Diluted EPS | 80.37% | 40.09% | 28.72% | 4.41% | -56.04% |
| Average Basic Shares Outstanding | 324.38% | 94.35% | 68.04% | 40.29% | 17.68% |
| Average Diluted Shares Outstanding | 324.38% | 94.35% | 68.04% | 40.29% | 15.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |